TCL Archive Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy July 26, 2013
TCL Archive Also in this 8-page issue: NCI advisors approve $15-million set-aside for laboratory testing on “reduced harm” tobacco products. July 9, 2004